Sanjiv Anand is a Nephrology physician affiliated with Intermountain Healthcare. OpenAlex indexes 28 publications with 607 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3702 S State St Ste 107
South Salt Lake, UT 841155096
Telephone
801-288-2634Provider last certified this registry record 30 Apr 2024.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year202527 payments$33,599openpaymentsdata.cms.gov ↗
- Alexion Pharmaceuticals, Inc.Program year202518 payments$14,221openpaymentsdata.cms.gov ↗
- Calliditas Therapeutics US Inc.Program year202513 payments$13,003openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
38.1%Corticosteroid24.5%Prednisone100%Part D≥22 patientsProton pump inhibitor13.5%Pantoprazole Sodium100%Part D≥12 patientsCardiovascular
36.1%Beta blocker12.9%Carvedilol100%Part D<11 patientsCalcium channel blocker8.4%Amlodipine Besylate100%Part D<11 patients+ 2 more classes in this area
Anti-infectives
17.4%Short-acting sulfonamides9%Sulfamethoxazole-Trimethoprim100%Part D<11 patientsCytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor8.4%Valganciclovir Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Elevations in Donor-Derived Cell-Free DNA and Allograft Outcomes in Kidney Transplantation
Journal of the American Society of Nephrology
2026 - Defining Relationships Among Tests for Kidney Transplant Antibody-Mediated Rejection
Kidney International Reports
2025 - Improving the histologic detection of donor-specific antibody-negative antibody-mediated rejection in kidney transplants
American Journal of Transplantation
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Brian Whisenant, MD
Intermountain Healthcare
William Sause, MD
Intermountain Healthcare
Nick Mamalis, MD
Intermountain Healthcare
Peggy Norton, MD
Intermountain Healthcare
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”